DrugPatentWatch Database Preview
ACIPHEX Drug Profile
Which patents cover Aciphex, and when can generic versions of Aciphex launch?
The generic ingredient in ACIPHEX is rabeprazole sodium. There are thirty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the rabeprazole sodium profile page.
Summary for ACIPHEX
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Suppliers / Packagers: | 4 |
| Bulk Api Vendors: | 65 |
| Clinical Trials: | 17 |
| Patent Applications: | 632 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | ACIPHEX at DailyMed |
Pharmacology for ACIPHEX
| Drug Class | Proton Pump Inhibitor |
| Mechanism of Action | Proton Pump Inhibitors |
Medical Subject Heading (MeSH) Categories for ACIPHEX
Synonyms for ACIPHEX
| (S)-Rabeprazole Sodium Salt |
| [2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]benzimidazol-1-yl]sodium |
| 1017795-22-0 |
| 117976-90-6 |
| 129982-41-8 |
| 171440-19-0 |
| 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, sodium salt |
| 1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt (1:1) |
| 1H-Benzimidazole,2-(((4-(3-methoxypropxy)-3-methyl-2-pyridinyl)methyl)sufinyl)-,sodium salt |
| 1H-Benzimidazole,2-[[[4-(3-methoxypropoxy)- 3-methyl-2-pyridinyl]methyl]sulfinyl]-,sodium salt |
| 2-(((4-(3-Methoxypropoxy)-3-methyl-2-pyridyl)methyl)sulfinyl)benzimidazole sodium salt |
| 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl]sulfinyl]-1 H -benzimidazole sodium salt |
| 226904-80-9 |
| 976R906 |
| AB0013367 |
| AC-715 |
| AC1Q1W5D |
| Aciphex (TN) |
| Aciphex Sodium |
| Aciphex Sprinkle |
| AK-94764 |
| AKOS015895734 |
| AKOS015962116 |
| AKOS025310160 |
| AM81231 |
| AN-15565 |
| API0004026 |
| AS-13338 |
| AX8150186 |
| BC208315 |
| BG0517 |
| C07865 |
| C18H20N3NaO3S |
| C18H20N3O3S.Na |
| CAS-117976-90-6 |
| CCG-213574 |
| CHEBI:8769 |
| CHEMBL1200930 |
| CR0021 |
| CTK8E9030 |
| D00724 |
| DR002161 |
| DSSTox_CID_24205 |
| DSSTox_GSID_44205 |
| DSSTox_RID_80118 |
| DTXSID3044205 |
| E 3810 |
| E3810 |
| EX-A176 |
| FT-0631090 |
| H932 |
| Habeprazole Sodium |
| HMS2093H10 |
| HMS2231E04 |
| HMS3373B05 |
| J-010726 |
| J10481 |
| KB-301660 |
| KRCQSTCYZUOBHN-UHFFFAOYSA-N |
| KS-00000H0Y |
| LS-172366 |
| LY 307640 sodium |
| LY-307640 |
| LY307640 sodium |
| MFCD02092688 |
| MLS001165734 |
| MLS006010621 |
| MolPort-003-850-098 |
| MolPort-003-986-282 |
| natrium-2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)benzimidazol-1-id |
| NCGC00159518-02 |
| NCGC00159518-05 |
| NCGC00255838-01 |
| Pariet |
| Pariet (TN) |
| pariete |
| Pariprazole sodium |
| Pepcia |
| Q-201655 |
| R0115 |
| RABEPRAZOLE SODIUM |
| Rabeprazole sodium (JP17/USAN) |
| Rabeprazole sodium [USAN] |
| Rabeprazole sodium salt |
| Rabeprazole sodium, >=98% (HPLC) |
| Rabicip |
| Rebeprazole sodium |
| Rebeprazole sodium salt |
| Rebeprazole sodium; |
| RTC-063564 |
| S-7685 |
| s4665 |
| SC-19471 |
| SCHEMBL140494 |
| SMR000550493 |
| sodium 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)benzimidazol-1-ide |
| sodium 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]benzimidazol-1-ide |
| SODIUM RABEPRAZOLE(1-) |
| sodium;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]benzimidazol-1-ide |
| ST24049115 |
| ST51052899 |
| TC-063564 |
| TL8000495 |
| Tox21_111736 |
| Tox21_111736_1 |
| Tox21_302317 |
US Patents and Regulatory Information for ACIPHEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eisai Inc | ACIPHEX | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 020973-001 | May 29, 2002 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Cerecor Inc | ACIPHEX SPRINKLE | rabeprazole sodium | CAPSULE, DELAYED RELEASE;ORAL | 204736-002 | Mar 26, 2013 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Eisai Inc | ACIPHEX | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 020973-002 | Aug 19, 1999 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Cerecor Inc | ACIPHEX SPRINKLE | rabeprazole sodium | CAPSULE, DELAYED RELEASE;ORAL | 204736-001 | Mar 26, 2013 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for ACIPHEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Eisai Inc | ACIPHEX | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 020973-002 | Aug 19, 1999 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Eisai Inc | ACIPHEX | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 020973-002 | Aug 19, 1999 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Eisai Inc | ACIPHEX | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 020973-001 | May 29, 2002 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Eisai Inc | ACIPHEX | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 020973-001 | May 29, 2002 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
